L1CAM and Parkinson disease: A study using a similar immunoprecipitation technique that also targeted L1CAM showed a highly significant increase in alpha-synuclein in L1CAM+ EVs in Parkinson's disease (PD) patients compared to controls, which also correlated with disease severity (Shi et al., 2014).